rs76130130
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_194322.3(OTOF):āc.68T>Gā(p.Ile23Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00517 in 1,587,232 control chromosomes in the GnomAD database, including 37 homozygotes. In-silico tool predicts a benign outcome for this variant. 10/12 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_194322.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTOF | NM_194248.3 | c.2215-77T>G | intron_variant | ENST00000272371.7 | NP_919224.1 | |||
OTOF | NM_194323.3 | c.-28+18T>G | intron_variant | ENST00000339598.8 | NP_919304.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOF | ENST00000272371.7 | c.2215-77T>G | intron_variant | 1 | NM_194248.3 | ENSP00000272371.2 | ||||
OTOF | ENST00000339598.8 | c.-28+18T>G | intron_variant | 1 | NM_194323.3 | ENSP00000344521.3 |
Frequencies
GnomAD3 genomes AF: 0.00341 AC: 519AN: 152096Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00430 AC: 866AN: 201304Hom.: 6 AF XY: 0.00414 AC XY: 448AN XY: 108272
GnomAD4 exome AF: 0.00535 AC: 7682AN: 1435018Hom.: 36 Cov.: 34 AF XY: 0.00517 AC XY: 3677AN XY: 711602
GnomAD4 genome AF: 0.00341 AC: 519AN: 152214Hom.: 1 Cov.: 32 AF XY: 0.00320 AC XY: 238AN XY: 74424
ClinVar
Submissions by phenotype
not provided Benign:4
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Aug 05, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2024 | OTOF: BP4, BS2 - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 23, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 07, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 30, 2012 | Ile23Ser in Exon 01 of OTOF: This variant is not expected to have clinical signi ficance because it has been identified in 0.5% (22/4104) of European American ch romosomes from a broad population by the NHLBI Exome Sequencing Project (http:// evs.gs.washington.edu/EVS; dbSNP rs76130130). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at